Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanming Hu

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Acta Oto-Laryngologica|July 1, 2009
Canal wall-down mastoidectomy with mastoid obliteration for pediatric cholesteatomaJiaqiang Sun, Jingwu Sun, Yanming Hu, et al.
Immunology|March 12, 2024
TREM1/DAP12 based novel multiple chain CAR-T cells targeting DLL3 show robust anti-tumour efficacy for small cell lung cancerFengqi Nie, Yuli Chen, Yanming Hu, et al.
Dalton Transactions (Cambridge, England : 2003)|August 3, 2013
Synthesis of bis(N-arylcarboximidoylchloride)pyridine cobalt(II) complexes and their catalytic behavior for 1,3-butadiene polymerizationHeng Liu, Xiangyu Jia, Feng Wang, et al.
Cell Death & Disease|August 16, 2025
TRIM31 triggers colorectal carcinogenesis and progression by maintaining YBX1 protein stability through ubiquitination modificationXiaoqing Li, Ying Wu, Jiahao Guo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 24, 2024
HCP5 Derived Novel Microprotein Triggers Progression of Gastric Cancer through Regulating FerroptosisQiuhui Li, Guoqing Guo, Yuli Chen, et al.
British Journal of Cancer|April 6, 2026
A novel microprotein L3EMP triggers lung adenocarcinoma progression by catalysing the deubiquitination of SIRT1Yuli Chen, Qinnan Chen, Qiuhui Li, et al.
Frontiers in Immunology|December 17, 2024
PD-L2 act as an independent immune checkpoint in colorectal cancer beyond PD-L1Lvyun Zhu, Ying Qu, Junru Yang, et al.
Nature Communications|September 27, 2024
The microprotein HDSP promotes gastric cancer progression through activating the MECOM-SPINK1-EGFR signaling axisYuli Chen, Qiuhui Li, Xiang Yu, et al.
Imeta|December 31, 2025
Genome-wide CRISPR screen reveals an uncharacterized spliceosome regulator as new candidate immunotherapy targetTong Shao, Chuanyang Liu, Jingyu Kuang, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Acta Oto-Laryngologica|July 1, 2009
Canal wall-down mastoidectomy with mastoid obliteration for pediatric cholesteatomaJiaqiang Sun, Jingwu Sun, Yanming Hu, et al.
Immunology|March 12, 2024
TREM1/DAP12 based novel multiple chain CAR-T cells targeting DLL3 show robust anti-tumour efficacy for small cell lung cancerFengqi Nie, Yuli Chen, Yanming Hu, et al.
Dalton Transactions (Cambridge, England : 2003)|August 3, 2013
Synthesis of bis(N-arylcarboximidoylchloride)pyridine cobalt(II) complexes and their catalytic behavior for 1,3-butadiene polymerizationHeng Liu, Xiangyu Jia, Feng Wang, et al.
Cell Death & Disease|August 16, 2025
TRIM31 triggers colorectal carcinogenesis and progression by maintaining YBX1 protein stability through ubiquitination modificationXiaoqing Li, Ying Wu, Jiahao Guo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 24, 2024
HCP5 Derived Novel Microprotein Triggers Progression of Gastric Cancer through Regulating FerroptosisQiuhui Li, Guoqing Guo, Yuli Chen, et al.
British Journal of Cancer|April 6, 2026
A novel microprotein L3EMP triggers lung adenocarcinoma progression by catalysing the deubiquitination of SIRT1Yuli Chen, Qinnan Chen, Qiuhui Li, et al.
Frontiers in Immunology|December 17, 2024
PD-L2 act as an independent immune checkpoint in colorectal cancer beyond PD-L1Lvyun Zhu, Ying Qu, Junru Yang, et al.
Nature Communications|September 27, 2024
The microprotein HDSP promotes gastric cancer progression through activating the MECOM-SPINK1-EGFR signaling axisYuli Chen, Qiuhui Li, Xiang Yu, et al.
Imeta|December 31, 2025
Genome-wide CRISPR screen reveals an uncharacterized spliceosome regulator as new candidate immunotherapy targetTong Shao, Chuanyang Liu, Jingyu Kuang, et al.
Pageof 3